Veliparib Hydrochloride
Tier C — Watch / tradeVeliparib Hydrochloride
Targets：PARP-2, PARP1
Indications (approved)：Glioblastoma, 神经胶质肉瘤, Metastatic breast cancer, Glioma, 星形细胞瘤, Myelofibrosis, 骨髓增生异常-骨髓增生性疾病, Acute myeloid leukaemia
Regional status
Synthetic routes & intermediates1 routes
Routes are ordered originator first, then optimised / process (non-patent) routes; each lists steps, overall yield and the intermediate table (code / CAS / name) — ready for supplier sourcing and RFQ. Rendered by this site from structured data; no third-party route graphics used.
| Code | CAS No. | Intermediate |
|---|---|---|
| VELI-001 | 108645-62-1 | 1-benzyl 2-methyl pyrrolidine-1,2-dicarboxylate |
| VELI-002 | 141870-95-3 | 1-benzyl 2-methyl 2-methylpyrrolidine-1,2-dicarboxylate |
| VELI-003 | 63427-91-8 | 1-((benzyloxy)carbonyl)-2-methylpyrrolidine-2-carboxylic acid |
| VELI-004 | 711007-44-2 | 2,3-diaminobenzamide |
| VELI-005 | 912444-71-4 | benzyl 2-((2-amino-3-carbamoylphenyl)carbamoyl)-2-methylpyrrolidine-1-carboxylate |
| VELI-006 | 912444-73-6 | (R)-benzyl 2-(4-carbamoyl-1H-benzo[d]imidazol-2-yl)-2-methylpyrrolidine-1-carboxylate |
Frequently asked questions
What are the approved indications of Veliparib Hydrochloride?
Approved indications include: Glioblastoma, 神经胶质肉瘤, Metastatic breast cancer, Glioma, 星形细胞瘤, Myelofibrosis, 骨髓增生异常-骨髓增生性疾病, Acute myeloid leukaemia.
When does the Veliparib Hydrochloride patent expire?
No public expiry year is available for Veliparib Hydrochloride yet; this page updates once verified.
How many synthesis routes are recorded for Veliparib Hydrochloride?
1 synthesis routes are recorded; the shortest is 5 steps with 254 mg total yield. Intermediates in each route carry codes and CAS numbers.
Where can I buy Veliparib Hydrochloride intermediates?
All intermediates in Veliparib Hydrochloride routes have CAS profiles — you can submit an RFQ per CAS and it enters the Unibest matching pool.
How do I get a quote for Veliparib Hydrochloride intermediates?
Open the CAS profile of the target intermediate from this page, or submit an RFQ directly — the CAS enters the matching flow automatically and the supply network responds with quotes.
Source: cross-verified data (structured fields only) · 2026-10-12